The risk of venous and arterial thrombosis in hyperhomocysteinaemia is low and mainly depends on concomitant thrombophilic defects

Journal: Thrombosis and Haemostasis
ISSN: 0340-6245

New concepts in vascular biology (Part I)

Issue: 2007: 98/2 (Aug) pp. 259-481
Pages: 457-563

The risk of venous and arterial thrombosis in hyperhomocysteinaemia is low and mainly depends on concomitant thrombophilic defects

Willem M. Lijfering 1, Michiel Coppens 2, Marlène H. W. van de Poel 1, Saskia Middeldorp 2, Karly Hamulyák 3, Ivan Bank 2, Nic J. G. M. Veeger 1, Martin H. Prins 4, Harry R. Büller 2, Jan van der Meer1
1 Division of Haemostasis, Thrombosis and Rheology, Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands; 2 Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands; 3 Department of Hematology, University Hospital Maastricht, Maastricht, The Netherlands; 4 Department of Clinical Epidemiology and Medical Technology Assessment, University Hospital Maastricht, Maastricht, The Netherlands.


Risk Factors, thrombophilia, Venous thrombosis, clinical studies, Arterial thrombosis


As homocysteine-lowering treatment has not reduced the risk of recurrent thrombosis in recent clinical trials,we hypothesized that mild hyperhomocysteinaemia is an epiphenomenon or associated with a low absolute risk of thrombosis. In this retrospective study, we enrolled 478 evaluable first-degree relatives of consecutive patients with venous thrombosis or premature atherosclerosis, and hyperhomocysteinemia. Absolute risks of thrombosis and effects of concomitant thrombophilic defects were compared. Relative risks were adjusted for clustering in families, age, sex, and atherosclerotic risk factors, where appropriate. Annual incidence of venous thrombosis was 0.16% (95% confidence interval [CI], 0.08–0.30) in hyperhomocysteinemic relatives versus 0.11% (CI, 0.05–0.20) in normohomocystei- nemic relatives; adjusted relative risk 1.6 (CI, 0.6–4.5). Annual incidences of arterial thrombosis were 0.34% (CI, 0.21–0.52) and 0.24% (CI, 0.15–0.37) in hyperhomocysteinemic and normohomocysteinemic relatives, respectively; adjusted relative risk 1.5 (CI, 0.6–3.5). Concomitance of multiple thrombophilic risk factors increased the risk of venous thrombosis in hyperhomocysteinemic relatives 20 fold, but a comparable effect was demonstrated in normohomocysteinemic relatives. We conclude that hyperhomocysteinaemia is associated with a low absolute risk of venous and arterial thrombosis. Concomitant thrombophilic defects are probably main determinants on the risk of venous thrombosis, rather than hyperhomocysteinaemia itself.

You may also be interested in...

From the Women’s Health Initiative Randomized Controlled Trial

M. Blondon (1, 2, 3), R. J. Rodabough (4), N. Budrys (5), K. C. Johnson (6), J. S. Berger (7), J. M. Shikany (8), A. Raiesdana (9), S. R. Heckbert (1, 2, 10), J. E. Manson (11), A. Z. LaCroix (12), D. Siscovick (13), B. Kestenbaum (1, 14, 15), N. L. Smith (1, 2, 10, 16), I. H. de Boer (1, 14)

Thromb Haemost 2015 113 5: 999-1009


Online Supplementary Material

Philip C. Bennett 1,2; Stanley H. Silverman 2; Paramjit S. Gill 3; Gregory Y. H. Lip1

Thromb Haemost 2009 101 6: 1032-1040

R. B. Zotz

Hämostaseologie 2008 28 3: 120-129